 |
chromium picolinate and chromium histidinate |
|---|---|
| Trade Name | |
| Orphan Indication | Pediatic polycystic ovary syndrome (0 through 16 years of age) |
| USA Market Approval | USA |
| USA Designation Date | 2014-12-22 00:00:00 |
| Sponsor | JDS Therapeutics, LLC;3 Manhattanville Rd, Suite 201;Purchase, New York, 10577 |
